Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Global Swine Healthcare Market by Product - Therapeutics (Vaccines, Parasiticides, Anti-infectives, Medicinal Feed Additives) by Product - Application (Diseases Caused by Bacteria, Mycoplasmas, and Spirochetes, Domestic Viral Diseases, Parasitic Diseases, Nutritional Deficiencies, Toxicoses and Poisonings, Exotic Viral Diseases, Skin Diseases) – Business Overview, Analysis and Industry Forecast 2017-2023

 Healthcare and Pharmaceuticals

Report Overview

Global Swine Healthcare Market was valued at USD XX Billion in the year 2017. Global Swine Healthcare Market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX Billion by the year 2023.

 

Asia Pacific region holds the highest market share in 2017 and is considered as the fastest growing market in the forecasted period. At the country level, India and China are the major markets in the Asia Pacific region and holds a substantial market share in 2017 and it is projected to grow at a gradual pace in the coming years.

The Swine Healthcare market is segmented on the basis of products and region. By product type, By Therapeutics was the largest type segment of the Swine Healthcare market in 2017 and is expected to grow with XX% CAGR in coming years.

Drivers:

            Intensifying Consumer Focus on Food Safety

Restraints:

            Increasing Foodborne Diseases

Opportunities:

            Increasing Export Demand for Pork

Challenges:

            Regulatory Challenges 

Zoetis, Merck, Merial, Elanco, Bayer Animal Health, Boehringer Ingelheim, Vetmedica, Novartis Animal Health, Virbac, Ceva Sante Animale, and Vetoquinol, among others, are some of the key players in the Global Swine Healthcare Market.

Key Benefits for Stakeholders

Swine health treatment drugs manufacturers

Raw material suppliers

Distributors & suppliers

Industry associations

Government & Regulatory agencies and organizations

By Product- Therapeutics

Vaccines

Parasiticides

Anti-infectives

Medicinal Feed Additives

Others

By Product- Application

Diseases Caused by Bacteria, Mycoplasmas, and Spirochetes

Domestic Viral Diseases

Parasitic Diseases

Nutritional Deficiencies

Toxicoses and Poisonings

Exotic Viral Diseases

Skin Diseases

Others

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

Bayer Animal Health

Boehringer Ingelheim

Ceva Sante Animale

Elanco

Merck

Merial

Novartis Animal Health

Vetmedica

Vetoquinol

Virbac

(Another brief information of 10 companies will be provided in a report.)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6.      Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottom-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Global Swine Healthcare Market, By Product- Therapeutics

6.1 Vaccines

6.2 Parasiticides

6.3 Anti-infectives

6.4 Medicinal Feed Additives

6.5 Others

7. Global Swine Healthcare Market, By Product- Application

7.1 Diseases Caused by Bacteria, Mycoplasmas, and Spirochetes

7.2 Domestic Viral Diseases

7.3 Parasitic Diseases

7.4 Nutritional Deficiencies

7.5 Toxicoses and Poisonings

7.6 Exotic Viral Diseases

7.7 Skin Diseases

7.8 Others

8. Geographical Analysis

8.1. Introduction

8.2. North America

       8.2.1. U.S.

       8.2.2. Canada

       8.2.3. Mexico

8.3. Europe

       8.3.1. U.K.

       8.3.2. Germany

       8.3.3. Italy

       8.3.4. France

       8.3.5. RoE

8.4. Asia Pacific

       8.4.1. South Korea

       8.4.2. China

       8.4.3. Japan

       8.4.4. South Korea

       8.4.5. RoAPAC

8.5. RoW

       8.5.1. Latin America

       8.5.2. Middle East and Africa

9. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

9.1 Bayer Animal Health

9.2 Boehringer Ingelheim

9.3 Ceva Sante Animale

9.4 Elanco

9.5 Merck

9.6 Merial

9.7 Novartis Animal Health

9.8 Vetmedica

9.9 Vetoquinol

9.10 Virbac

(Another brief information of 10 companies will be provided in a report.)

10. Competitive Analysis

10.1. Introduction

10.2. Market Positioning of Key Players

10.3 Competitive Strategies Adopted by Leading Players

        10.3.1. Investments & Expansions

        10.3.2. New Product Launches

        10.3.3. Mergers & Acquisitions

        10.3.4. Agreements, Joint Ventures, and Partnerships

11. Appendix

11.1. Questionnaire

11.2. Available Customizations 

11.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

* The list of tables and figures will be provided in the sample report.

Summary

No Content Available.

PURCHASE OPTIONS

ASK FOR SPECIAL PRICING

Related Reports